3Cittanova ML. Is perioperative renal dysfunction of no consequence? [J]. Br J Anaesth,2001,86(2) :164-166.
4Sear JW. Kidney dysfunction in the post operative period[ J]. Br J Anaesth,2005, 95 ( 1 ) :20-32.
5Dharnidharka VR, Kwon C, Stephens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis[J]. Am J Kidney Dis,2002,40(2) :221-226.
6Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery [ J ]. Lancet,2005,365 ( 9466 ) : 1231-1238.
7Halpenny M, Lakshmi S, O Donnell A, et al. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting[ J]. Anaesthesia,2001,56(10) :953-960.
8Tumlin JA, Finkel KW, Murray PT, et al. Fenoldopam mesylate in early acute tubular necrosis: a randomised, double-blind, placebocontrolled clinical trial[J]. Am J Kidney Dis, 2005,46( 1 ) :26-34.
9Hashiguchi H, Morooka H, Miyoshi H, et al. Isoflurane protects renal function against ischaemia and reperfusion through inhibition of protein kinases, JNK and ERK[J]. Anesth Analg,2005, 101 (6) : 1584-1589.
10Hladunewieh MA, Corrigan G, Derby GC. A randomized, place-bo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARF [ J ]. Kidney Int,2003,64 (2) : 593 -602.
